Winningham Rick E: insider trades.
Winningham Rick E reported 9 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 2 companies.
- Transactions
- 9
- Purchases (P)
- 0
- Sales (S)
- 0
- Companies
- 2
- Name as filed
- Winningham Rick E
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | Director, Officer · CHIEF EXECUTIVE OFFICER | 6 |
| Jazz Pharmaceuticals plc (JAZZ) | Director | 3 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-23 | Theravance Biopharma, Inc. | D | 1,382,272 | — | 228,750 | Form 4 |
| 2026-09-23 | Theravance Biopharma, Inc. | D | 92,567 | — | 0 | Form 4 |
| 2026-09-23 | Theravance Biopharma, Inc. | D | 23,400 | — | 0 | Form 4 |
| 2026-09-23 | Theravance Biopharma, Inc. | D | 151,875 | — | 76,875 | Form 4 |
| 2026-09-23 | Theravance Biopharma, Inc. | D | 76,875 | — | 0 | Form 4 |
| 2026-08-31 | Jazz Pharmaceuticals plc | F | 14 | $244.64 | 9,466 | Form 4 |
| 2026-08-31 | Jazz Pharmaceuticals plc | F | 1,692 | $241.39 | 9,480 | Form 4 |
| 2026-08-20 | Theravance Biopharma, Inc. | F | 20,034 | $16.95 | 1,611,022 | Form 4 |
| 2026-08-05 | Jazz Pharmaceuticals plc | A | 1,605 | $0 | 11,172 | Form 4 |
Questions
What stock did Winningham Rick E buy or sell?
Winningham Rick E reported 9 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 2 companies.
Is Winningham Rick E the same person as other filers with this name?
This page covers SEC CIK 1302443 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/winningham-rick-e-1302443.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.